Intertek has signed a Memorandum of Understanding (MoU) with PRECISE, a leading distributor of corporate products in the Gulf, to test its antimicrobial protective films for high-contact surfaces
Intertek, a total quality assurance provider, will exclusively provide independent COVID-19 SWAB testing for MEDG, the nano-copper antimicrobial film solution from PRECISE.
Intertek’s COVID-19 testing service is part of Intertek Protek, the world’s first health, safety and wellbeing assurance programme for people, workplaces and public spaces.
The Protek programme provides support across all sectors, from manufacturing to retail sites to public places, schools, hospitals, transport, banks, amongst others. As part of the MoU, Intertek will offer COVID-19 surface testing services to PRECISE customers to independently verify the product’s performance. PRECISE has launched its bacteria and virus resisting transparent films in the UAE and Saudi markets.
A pre-launch campaign saw the company apply its antimicrobial protective films on high-contact touch surfaces of a public bus. After a month-long trial that included only standard cleaning and maintenance, Intertek conducted surface testing of the film-protected surfaces from high-traffic areas on the public vehicle and verified that the active antimicrobial nano copper films were COVID-19 free after 28 days at the end of the trial period.
Lother Hohman, president of PRECISE, said, “Active Antimicrobial Nano Copper technology uses active copper nanoparticles that deactivate pathogens with amazing results. Copper ions quickly inactivate viruses and bacteria by immobilising all life support systems in their cells. Science tells us that applying the protective nano-copper anti-microbial film helps to reduce the risks of cross-contamination. This novel composite film also significantly reduces the direct cost of continuous disinfection protocols through traditional methods.”
Samir Ahmed, regional director for products and marketing for the Middle East, North Africa and Pakistan at Intertek, stated, “Intertek has been at the forefront, driving a health, safety, and well-being assurance agenda globally when it launched its Protek solution, the first comprehensive offering in the world for quality assurance services that provide the confidence people need to operate in the post-COVID-19 ‘new normal’.
“Intertek uses cutting-edge technology and solutions to test and verify germicidal devices and products to support manufacturers who wish to assess equipment performance and compliance in the impacted environment. Our collaboration with PRECISE is aligned with our global and regional strategies and will provide our clients the peace of mind they need to live and work safely in a protected environment.”
